• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染患者肺及支气管肺泡灌洗液样本的转录组分析显示,感染后主要表现为 B 细胞激活反应。

Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.

机构信息

Department of Biomedical and Biotechnological Sciences, University of Catania, I‑95123 Catania, Italy.

IRCCS (Scientific Institute for Research, Hospitalization and Healthcare) Centro Neurolesi 'Bonino‑Pulejo', I‑98124 Messina, Italy.

出版信息

Int J Mol Med. 2020 Oct;46(4):1266-1273. doi: 10.3892/ijmm.2020.4702. Epub 2020 Aug 12.

DOI:10.3892/ijmm.2020.4702
PMID:32945352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7447313/
Abstract

The outbreak of the 2019 coronavirus disease (named, COVID‑19), caused by the novel SARS‑CoV‑2 virus, represents a worldwide severe threat to public health. It is of the utmost importance to characterize the immune responses against the SARS‑CoV‑2 and the mechanisms of hyperinflammation, in order to design better therapeutic strategies for COVID‑19. In the present study, a transcriptomic analysis was performed to profile the immune signatures in lung and the bronchoalveolar lavage fluid samples from COVID‑19 patients and controls. Our data concordantly revealed increased humoral responses to infection. The elucidation of the host responses to SARS‑CoV‑2 infection may further improve our understanding of COVID‑19 pathogenesis and suggest better therapeutic strategies.

摘要

2019 年冠状病毒病(命名为 COVID-19)的爆发是由新型 SARS-CoV-2 病毒引起的,这对全球公共卫生构成了严重威胁。描述针对 SARS-CoV-2 的免疫反应和过度炎症的机制非常重要,以便为 COVID-19 设计更好的治疗策略。在本研究中,进行了转录组分析以描绘 COVID-19 患者和对照者的肺和支气管肺泡灌洗液样本中的免疫特征。我们的数据一致显示出对感染的体液反应增加。阐明宿主对 SARS-CoV-2 感染的反应可能会进一步加深我们对 COVID-19 发病机制的理解,并提出更好的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/7447313/889dd910d88c/IJMM-46-04-1266-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/7447313/65751a7356d0/IJMM-46-04-1266-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/7447313/14c469624626/IJMM-46-04-1266-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/7447313/6957af0c261d/IJMM-46-04-1266-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/7447313/889dd910d88c/IJMM-46-04-1266-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/7447313/65751a7356d0/IJMM-46-04-1266-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/7447313/14c469624626/IJMM-46-04-1266-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/7447313/6957af0c261d/IJMM-46-04-1266-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b0/7447313/889dd910d88c/IJMM-46-04-1266-g03.jpg

相似文献

1
Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.新冠病毒感染患者肺及支气管肺泡灌洗液样本的转录组分析显示,感染后主要表现为 B 细胞激活反应。
Int J Mol Med. 2020 Oct;46(4):1266-1273. doi: 10.3892/ijmm.2020.4702. Epub 2020 Aug 12.
2
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.新型冠状病毒肺炎患者支气管肺泡灌洗液和外周血单个核细胞的转录组学特征。
Emerg Microbes Infect. 2020 Dec;9(1):761-770. doi: 10.1080/22221751.2020.1747363.
3
A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.新冠病毒患者样本与人感觉神经元的药物相互作用组揭示了神经源性肺功能障碍的潜在驱动因素。
Brain Behav Immun. 2020 Oct;89:559-568. doi: 10.1016/j.bbi.2020.05.078. Epub 2020 Jun 1.
4
Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.基于转录组学特征的方法研究催产素在 COVID-19 中的抗炎和免疫促进作用。
Physiol Genomics. 2020 Sep 1;52(9):401-407. doi: 10.1152/physiolgenomics.00095.2020. Epub 2020 Aug 18.
5
Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.基于转录组数据再利用的 COVID-19 免疫和代谢特征。
Front Immunol. 2020 Jun 26;11:1636. doi: 10.3389/fimmu.2020.01636. eCollection 2020.
6
SARS-CoV-2 infection protects against rechallenge in rhesus macaques.SARS-CoV-2 感染可使恒河猴免受再次感染。
Science. 2020 Aug 14;369(6505):812-817. doi: 10.1126/science.abc4776. Epub 2020 May 20.
7
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.COVID-19 患者呼吸道中的先天免疫反应增强。
Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2. doi: 10.1016/j.chom.2020.04.017. Epub 2020 May 4.
8
Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.宿主依赖性 RNA 编辑在 SARS-CoV-2 转录组中的证据。
Sci Adv. 2020 Jun 17;6(25):eabb5813. doi: 10.1126/sciadv.abb5813. eCollection 2020 Jun.
9
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.ChAdOx1 nCoV-19 疫苗可预防恒河猴的 SARS-CoV-2 肺炎。
Nature. 2020 Oct;586(7830):578-582. doi: 10.1038/s41586-020-2608-y. Epub 2020 Jul 30.
10
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.涉及 RAS 介导的缓激肽风暴的 COVID-19 的机械模型和治疗干预。
Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.

引用本文的文献

1
Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine.解锁RNA测序在新冠病毒肺炎中的潜力:迈向精准诊断与个性化医疗
Diagnostics (Basel). 2025 Jan 20;15(2):229. doi: 10.3390/diagnostics15020229.
2
The effects of iron deficient and high iron diets on SARS-CoV-2 lung infection and disease.缺铁和高铁饮食对新型冠状病毒肺炎肺部感染及疾病的影响。
Front Microbiol. 2024 Sep 4;15:1441495. doi: 10.3389/fmicb.2024.1441495. eCollection 2024.
3
Exploring the Role of CD74 and D-Dopachrome Tautomerase in COVID-19: Insights from Transcriptomic and Serum Analyses.

本文引用的文献

1
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.冠状病毒抗体介导免疫的系统评价:动力学、保护相关性及与严重程度的关系。
Nat Commun. 2020 Sep 17;11(1):4704. doi: 10.1038/s41467-020-18450-4.
2
Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom.外周嗅觉受体与 SARS-CoV-2 感染介质的共表达:嗅觉丧失作为 COVID-19 症状之外的潜在影响。
Int J Mol Med. 2020 Sep;46(3):949-956. doi: 10.3892/ijmm.2020.4646. Epub 2020 Jun 17.
3
Clinical characteristics of 2019 novel coronavirus pneumonia in Zhejiang province, China.
探索CD74和D-多巴色素互变异构酶在COVID-19中的作用:转录组学和血清分析的见解
J Clin Med. 2023 Jul 31;12(15):5037. doi: 10.3390/jcm12155037.
4
Differential Gene Expression of SARS-CoV-2 Positive Bronchoalveolar Lavages: A Case Series.SARS-CoV-2 阳性支气管肺泡灌洗液的差异基因表达:一项病例系列研究。
Pathobiology. 2024;91(2):158-168. doi: 10.1159/000532057. Epub 2023 Jul 25.
5
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of L.鞣花酸和 L. 的多酚的抗 COVID-19 潜力
Molecules. 2023 Apr 27;28(9):3772. doi: 10.3390/molecules28093772.
6
Shared 6mer Peptides of Human and Omicron (21K and 21L) at SARS-CoV-2 Mutation Sites.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异位点处人类与奥密克戎(21K和21L)的共享六聚体肽段
Antibodies (Basel). 2022 Oct 25;11(4):68. doi: 10.3390/antib11040068.
7
The current status of gene expression profilings in COVID-19 patients.COVID-19患者基因表达谱分析的现状。
Clin Transl Discov. 2022 Sep;2(3):e104. doi: 10.1002/ctd2.104. Epub 2022 Jul 17.
8
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs.阿尔茨海默病致病途径的计算分析及潜在治疗药物预测
Brain Sci. 2022 Jun 24;12(7):827. doi: 10.3390/brainsci12070827.
9
‎Factors associated with coronavirus disease 2019 infection severity among a sample of Lebanese adults: Data from a cross-sectional study.黎巴嫩成年人样本中与2019冠状病毒病感染严重程度相关的因素:一项横断面研究的数据
Health Sci Rep. 2022 May 23;5(3):e654. doi: 10.1002/hsr2.654. eCollection 2022 May.
10
Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection.利用慢病毒 hACE2 载体在小鼠中模拟 SARS-CoV-2 感染,推断出两种针对 SARS-CoV-2 感染的免疫反应模式。
Viruses. 2021 Dec 21;14(1):11. doi: 10.3390/v14010011.
中国浙江省 2019 年新型冠状病毒肺炎的临床特征。
Mol Med Rep. 2020 Sep;22(3):2583-2587. doi: 10.3892/mmr.2020.11329. Epub 2020 Jul 10.
4
Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis.无症状 2019 冠状病毒病的比例:系统评价和荟萃分析。
J Med Virol. 2021 Feb;93(2):820-830. doi: 10.1002/jmv.26326. Epub 2020 Aug 13.
5
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
Immunol Res. 2020 Aug;68(4):213-224. doi: 10.1007/s12026-020-09145-5.
6
[Editorial] COVID‑19: Post‑lockdown guidelines.[社论] COVID-19:封锁后指导方针。
Int J Mol Med. 2020 Aug;46(2):463-466. doi: 10.3892/ijmm.2020.4640. Epub 2020 Jun 12.
7
A dissection of SARS‑CoV2 with clinical implications (Review).SARS-CoV-2 的临床意义剖析(综述)。
Int J Mol Med. 2020 Aug;46(2):489-508. doi: 10.3892/ijmm.2020.4636. Epub 2020 Jun 10.
8
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).将 COVID-19 相关血栓形成纳入继发性抗磷脂抗体综合征:诊断和治疗观点(综述)。
Int J Mol Med. 2020 Sep;46(3):903-912. doi: 10.3892/ijmm.2020.4659. Epub 2020 Jun 25.
9
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm.严重 COVID-19:高铁蛋白血症综合征之谜的又一块拼图。免疫调节观点缓解炎症风暴。
Front Immunol. 2020 May 28;11:1130. doi: 10.3389/fimmu.2020.01130. eCollection 2020.
10
Covid-19 and autoimmunity.新冠病毒与自身免疫
Autoimmun Rev. 2020 Aug;19(8):102597. doi: 10.1016/j.autrev.2020.102597. Epub 2020 Jun 11.